Trials / Completed
CompletedNCT02519088
A New Approach to a Personalized Patient Blood Management Program (pPBM) in Total Hip Arthroplasty (THA)
A New Approach to a Personalized Patient Blood Management Program in Total Hip Arthroplasty
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 477 (actual)
- Sponsor
- Krankenhaus der Barmherzigen Brüder Trier · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The study evaluates the patient related risk and predictive factors concerning perioperative homologous blood cell transfusion (erythrocyte concentrate ) in THA patients in one EndoCert max-certified orthopedic hospital in Germany. A patient oriented preoperative decision-making algorithm (a personalised Patient Blood Management or pPBM App) will be developed as a new patient-safety blood-sparing strategy. The aim is to increase the patient safety by using the pPBM App and to reach a more efficient management of resources.
Detailed description
Retrospective audit of 470 consecutive primary THA in 2013 and 2014
Conditions
Timeline
- Start date
- 2015-08-01
- Primary completion
- 2015-10-01
- Completion
- 2015-10-01
- First posted
- 2015-08-10
- Last updated
- 2015-10-12
Locations
1 site across 1 country: Germany
Source: ClinicalTrials.gov record NCT02519088. Inclusion in this directory is not an endorsement.